Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$688.96M
Close$
$1.15
145.2% upside
Current Fair Value
145.2% upsideUndervalued by 145.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $688.96 Million |
|---|---|
| Enterprise Value | $2.31 Billion |
| Annual dividend | $0.02 |
| Dividend yield | 1.56% |
| Earnings per Share | $0.24 |
| Beta | 0.31 |
| Outstanding Shares | 1,467,118,004 |
Return
| Return on Equity | 1.70% |
|---|---|
| Return on Assets | 1.23% |
| Return on Invested Capital | 2.36% |
Valuation & Multiples
| P/E Ratio | 66.4 |
|---|---|
| PEG | -99.21 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | 7.83 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 1.36 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
2,150 employees
CEO: Li Li
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is an international pharmaceutical enterprise specializing in the production and commercialization of medicinal products. Its operations span Hong Kong, the United States, Europe, Mainland...